GE Healthcare reports positive data for imaging agent
GE Healthcare has reported positive data from studies of a new imaging agent that can be used in the diagnosis of Alzheimer's disease.
GE Healthcare, a unit of General Electric Company, announced that it has entered into an agreement to acquire the assets of Orbotech Medical Solutions Ltd., a subsidiary of Orbotech Ltd., and a manufacturer of cadmium zinc telluride detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.